737 results on '"Chen, Zhe-Sheng"'
Search Results
2. Nanotechnology-based delivery systems to overcome drug resistance in cancer
3. Synthesis and clinical application of new drugs approved by FDA in 2022
4. Advancements in clinical aspects of targeted therapy and immunotherapy in breast cancer
5. Epigenetic modification of m6A regulator proteins in cancer
6. Gold nanoparticles and gold nanorods in the landscape of cancer therapy
7. Stellettin B renders glioblastoma vulnerable to poly (ADP-ribose) polymerase inhibitors via suppressing homology-directed repair
8. Tumor cell plasticity in targeted therapy-induced resistance: mechanisms and new strategies
9. Advancements in nanoparticle-based treatment approaches for skin cancer therapy
10. New opportunities for RGD-engineered metal nanoparticles in cancer
11. Electroacupuncture facilitates vascular normalization by inhibiting Glyoxalase1 in endothelial cells to attenuate glycolysis and angiogenesis in triple-negative breast cancer
12. Hepatocellular carcinoma and lipid metabolism: Novel targets and therapeutic strategies
13. New insights into the mechanism of resistance to lenvatinib and strategies for lenvatinib sensitization in hepatocellular carcinoma
14. Targeting anoikis resistance as a strategy for cancer therapy
15. VISTA: A Novel Checkpoint for Cancer Immunotherapy
16. Dostarlimab in the treatment of mismatch repair deficient recurrent or advanced endometrial cancer
17. Stepwise targeted strategies for improving neurological function by inhibiting oxidative stress levels and inflammation following ischemic stroke
18. Targeting autophagy to counteract neuroinflammation: A novel antidepressant strategy
19. Ferroptosis as a potential therapeutic target for age-related macular degeneration
20. ABCB1-dependent collateral sensitivity of multidrug-resistant colorectal cancer cells to the survivin inhibitor MX106-4C
21. Targeting ZIP8 mediated ferroptosis as a novel strategy to protect against the retinal pigment epithelial degeneration
22. Overexpression of ABCC1 and ABCG2 confers resistance to talazoparib, a poly (ADP-Ribose) polymerase inhibitor
23. AR/RKIP pathway mediates the inhibitory effects of icariin on renal fibrosis and endothelial-to-mesenchymal transition in type 2 diabetic nephropathy
24. Ligands and receptors in human cytomegalovirus entry: Current therapies and new directions
25. Recent review of COVID-19 management: diagnosis, treatment and vaccination
26. SETD4 inhibits prostate cancer development by promoting H3K27me3-mediated NUPR1 transcriptional repression and cell cycle arrest
27. Inhibition of phosphoglycerate dehydrogenase induces ferroptosis and overcomes enzalutamide resistance in castration-resistant prostate cancer cells
28. Cancer nuclear envelope rupture and repair in taxane resistance
29. Lansoprazole (LPZ) reverses multidrug resistance (MDR) in cancer through impeding ATP-binding cassette (ABC) transporter-mediated chemotherapeutic drug efflux and lysosomal sequestration.
30. lncRNA SYTL5-OT4 promotes vessel co-option by inhibiting the autophagic degradation of ASCT2
31. A multi-functional nano-system combining PI3K-110α/β inhibitor overcomes P-glycoprotein mediated MDR and improves anti-cancer efficiency
32. Recent advances in biomimetic nanodelivery systems: New brain-targeting strategies
33. Design, synthesis, and biological evaluation of phenylurea indole derivatives as ABCG2 inhibitors
34. Susceptibility of Lung Carcinoma Cells to Nanostructured Lipid Carrier of ARV-825, a BRD4 Degrading Proteolysis Targeting Chimera
35. Antimicrobial peptides for combating drug-resistant bacterial infections
36. Silver-dendrimer nanocomposite as emerging therapeutics in anti-bacteria and beyond
37. Sunitinib resistance in renal cell carcinoma: From molecular mechanisms to predictive biomarkers
38. Therapeutic Implication of Oxidative Stress Regulators in Drug-Resistant Cancers
39. Application of Stimuli-Responsive Polymers in Cancer Therapy
40. An Overview of Antioxidative Anticancer Therapies with Reference to the Cancer Stem Cells
41. Evaluation of the Anticancer Activities of Isatin-Based Derivatives
42. Efficacy of Synthetic Organic Molecule Inhibitors of TRAF2 and NCK-Interacting Kinase (TNIK) Against Colorectal Cancer
43. Arylboronic Acids and Ester-Based Prodrugs Targeting Oxidative Stress in Cancer
44. Applications of Peptide in Cancer Therapy
45. Pristimerin in Oxidative Stress and Use in Cancer
46. Small Molecule Inhibitors That Target Signal Transduction Pathways Involved in Oxidative Stress-Induced Cancer : Current Status and Future Directions
47. Polyphenolic Acetates as Potential Therapeutics and Adjuvant in Radiotherapy of Cancer
48. Synthetic Small Molecules in Prostate Cancer Therapeutics
49. Therapeutic Efficacy of Roscovitine Against Cancer
50. A Critical Appraisal of Current Status of Synthetic Antioxidant Molecules in the Treatment of Breast Cancer
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.